Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

2.

A phase II trial of concurrent chemoradiation therapy followed by consolidation chemotherapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancers.

Park J, Ahn YC, Kim H, Lee SH, Park SH, Lee KE, Lim DH, Park J, Kim K, Jung CW, Im YH, Kang WK, Lee MH, Park K.

Lung Cancer. 2003 Nov;42(2):227-35.

PMID:
14568691
3.

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.

Hanna N, Neubauer M, Yiannoutsos C, McGarry R, Arseneau J, Ansari R, Reynolds C, Govindan R, Melnyk A, Fisher W, Richards D, Bruetman D, Anderson T, Chowhan N, Nattam S, Mantravadi P, Johnson C, Breen T, White A, Einhorn L; Hoosier Oncology Group.; US Oncology..

J Clin Oncol. 2008 Dec 10;26(35):5755-60. doi: 10.1200/JCO.2008.17.7840.

PMID:
19001323
4.
5.

Concomitant chemoradiotherapy with cisplatin and docetaxel followed by surgery and consolidation chemotherapy in patients with unresectable locally advanced non-small cell lung cancer.

Kaya AO, Buyukberber S, Benekli M, Coskun U, Sevinc A, Akmansu M, Yildiz R, Ozturk B, Yaman E, Kalender ME, Orhan O, Yamac D, Uner A; Anatolian Society of Medical Oncology (ASMO)..

Med Oncol. 2010 Mar;27(1):152-7. doi: 10.1007/s12032-009-9186-z.

PMID:
19242825
7.

[Concurrent chemoradiotherapy with low-dose weekly docetaxel followed by consolidation chemotherapy with docetaxel and cisplatin in the treatment of stage III non-small cell lung cancer.].

Liu X, Chen H, Xiao T, Jin Y, Chen H.

Zhongguo Fei Ai Za Zhi. 2008 Feb 20;11(1):79-84. doi: 10.3779/j.issn.1009-3419.2008.01.018. Chinese.

8.

Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).

Thomas CR Jr, Giroux DJ, Stelzer KJ, Craig JB, Laufman LR, Taylor SA, Goodwin JW, Crowley JJ, Livingston RB.

Int J Radiat Oncol Biol Phys. 1998 Mar 15;40(5):1039-47.

PMID:
9539558
9.

Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504.

Gandara DR, Chansky K, Albain KS, Leigh BR, Gaspar LE, Lara PN Jr, Burris H, Gumerlock P, Kuebler JP, Bearden JD 3rd, Crowley J, Livingston R; Southwest Oncology Group..

J Clin Oncol. 2003 May 15;21(10):2004-10.

PMID:
12743155
10.

Concomitant chemoradiotherapy with docetaxel and cisplatin followed by consolidation chemotherapy in locally advanced unresectable non-small cell lung cancer.

Eroglu C, Orhan O, Unal D, Dogu GG, Karaca H, Dikilitas M, Ozt├╝rk A, Ozkan M, Kaplan B.

Ann Thorac Med. 2013 Apr;8(2):109-15. doi: 10.4103/1817-1737.109824.

11.

Weekly docetaxel and cisplatin with concomitant radiotherapy in addition to surgery and/or consolidation chemotherapy in stage III non-small cell lung cancer.

Sen F, Saglam EK, Toker A, Dilege S, Kizir A, Oral EN, Saip P, Sakallioglu B, Topuz E, Aydiner A.

Cancer Chemother Pharmacol. 2011 Dec;68(6):1497-505. doi: 10.1007/s00280-011-1642-8.

PMID:
21499895
12.
14.

Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer.

Chen LM, Ignacio L, Jacobs R, Kozloff M, Telfer M, Elahi R, Evans R, Vijayakumar S.

Radiat Oncol Investig. 1999;7(1):49-53.

PMID:
10030624
15.

Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.

Reboul F, Brewer Y, Vincent P, Chauvet B, Faure CF, Taulelle M.

Int J Radiat Oncol Biol Phys. 1996 May 1;35(2):343-50.

PMID:
8635942
16.
17.

Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.

Chen GY, Jiang GL, Wang LJ, Qian H, Fu XL, Yang H, Wu KL, Zhao S.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):70-5.

PMID:
15629596
18.

Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).

Gandara DR, Chansky K, Albain KS, Gaspar LE, Lara PN Jr, Kelly K, Crowley J, Livingston R.

Clin Lung Cancer. 2006 Sep;8(2):116-21.

PMID:
17026812
19.

[Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].

Li JL, Zhang XR, Liu JW, Chen ZY, Lin YC, Wang YD, Chen Q, Nan KJ, Song SP, Han FC, Zhu YZ, Li LY, Zheng YH, Chu DT.

Zhonghua Zhong Liu Za Zhi. 2006 Apr;28(4):309-12. Chinese.

PMID:
16875636
20.

Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer.

Iwasaki Y, Ohsugi S, Natsuhara A, Tsubokura T, Harada H, Ueda M, Arimoto T, Hara H, Yamada T, Takesako T, Kohno K, Hosogi S, Nakanishi M, Marunaka Y, Nishimura T.

Cancer Chemother Pharmacol. 2006 Dec;58(6):735-41.

PMID:
16565832

Supplemental Content

Support Center